Elucidating the Impact of Hypericum alpestre Extract and L-NAME on the PI3K/Akt Signaling Pathway in A549 Lung Adenocarcinoma Cells
Authors:
- Hayarpi JavrushyanHJHayarpi Javrushyan
- Mikayel GinovyanMGMikayel Ginovyan
- Gayane PetrosyanGPGayane Petrosyan
- Mery QocharyanMQMery Qocharyan
- Tigran HarutyunyanTHTigran Harutyunyan
- Smbat GevorgyanSGSmbat Gevorgyan
- Zaruhi KarabekianZKZaruhi Karabekian
- Alina MaloyanAMAlina Maloyan
- Nikolay AvtandilyanNANikolay Avtandilyan
Preprint
Abstract
Plants within the Hypericaceae family have been traditionally used for their medicinal properties, showcasing a wide range of effects such as antibacterial, antiviral, and antioxidant qualities. Hypericum alpestre (HA) extracts have exhibited significant cytotoxicity against various cancer cell lines. The phenolic compounds found in HA extracts have attracted attention for their potential in cancer prevention. L-NAME, known for its ability to inhibit nitric oxide synthase (NOS) activity, has emerged as a promising approach in cancer therapy. However, the precise molecular mechanisms underlying the anticancer effects of HA and L-NAME remain unclear. This study aims to clarify the impact of HA and L-NAME on the PI3K/Akt signaling pathway in A549 lung adenocarcinoma cells, with a specific focus on TNFa/COX-2 and VEGFa/MMP-2 pathways. In silico analysis, they identified the compounds with the highest affinity for PI3K/Akt, a finding validated by subsequent in vitro experiments. Furthermore, the combination of herbs and L-NAME exhibited superior efficacy compared to the herb and 5-FU combination, as evidenced by the promotion of apoptosis. Both the herb alone and the combination of the herb with L-NAME demonstrated inhibitory effects on the TNFa/COX-2 and VEGFa/MMP-2 pathways. This therapeutic approach is hypothesized to operate through the PI3k/Akt cell signaling pathway. A better understanding of the interaction between HA polyphenols and PI3K/Akt signaling could pave the way for novel therapeutic strategies against cancer, including drug-resistant tumors.Keywords
This publication has 27 references indexed in Scilit:
- Hypericum alpestre extract exhibits in vitro and in vivo anticancer properties by regulating the cellular antioxidant system and metabolic pathway of L‐arginineCell Biochemistry and Function, 2024
- Anti-cancer effect of Rumex obtusifolius in combination with arginase/nitric oxide synthase inhibitors via downregulation of oxidative stress, inflammation, and polyamine synthesisThe International Journal of Biochemistry & Cell Biology, 2023
- Anti-cancer effect of in vivo inhibition of nitric oxide synthase in a rat model of breast cancerMolecular and Cellular Biochemistry, 2022
- Phytochemical Screening and Detection of Antibacterial Components from Crude Extracts of Some Armenian Herbs Using TLC-Bioautographic TechniqueCurrent Microbiology, 2020
- The PI3K Pathway in Human DiseaseCell, 2017
- Juices from non-typical edible fruits as health-promoting acidity regulators for food industryLWT, 2015
- Arginase, Nitric Oxide Synthase, and Novel Inhibitors of L-arginine Metabolism in Immune Modulation2013
- Protective Effects of YC-1 Against Glutamate Induced PC12 Cell ApoptosisCellular and Molecular Neurobiology, 2010
- Ligand docking and binding site analysis with PyMOL and Autodock/VinaJournal of Computer-Aided Molecular Design, 2010
- Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis2009